Location History:
- Berlin, DE (2010 - 2012)
- Bethesda, MD (US) (2014)
Company Filing History:
3 out of 3,539 
2 out of 1,384 
Years Active: 2010-2014
Title: Frank Heller: Innovator in Colitis Treatment
Introduction
Frank Heller is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of medical research, particularly in the treatment of colitis. With a total of three patents to his name, Heller's work focuses on innovative methods to address inflammatory responses associated with this condition.
Latest Patents
Heller's latest patents include groundbreaking methods of treating and preventing colitis involving IL-13 and NK-T cells. One of his inventions provides a method for treating or preventing the inflammatory response of colitis in a subject by administering an effective amount of a substance that modulates IL-13 activity. Additionally, he has developed a method that involves modulating NK-T cell activity to achieve similar therapeutic effects. His inventions also encompass the screening of substances that can treat or prevent the inflammatory response of colitis.
Career Highlights
Throughout his career, Frank Heller has worked with prestigious organizations such as the National Institutes of Health, a component of the US Department of Health & Human Services, and The Brigham and Women's Hospital, Inc. His experience in these institutions has allowed him to advance his research and contribute to the medical community.
Collaborations
Heller has collaborated with esteemed colleagues, including Warren Strober and Ivan J Fuss. These partnerships have further enriched his research and innovation in the field of colitis treatment.
Conclusion
Frank Heller's contributions to the treatment of colitis through his innovative patents highlight his dedication to improving patient outcomes. His work continues to influence the medical field and offers hope for those affected by this condition.